Neuropathic Ocular Pain Epidemiology Summary

Neuropathic Ocular Pain (NOP) Insights and Trends

• According to DelveInsight’s estimates, in 2025, NOP cases were distributed across the 7MM, with the highest share observed in the US, followed by the EU4 and the UK, while Japan accounted for a comparatively smaller proportion of cases.
• According to National Organization for Rare Disorders (NORD) (2025), the exact number of people affected by NOP is not known yet. 
• The proportion of females affected by NOP is higher than that of males, and women also tend to experience a greater incidence of associated conditions such as fibromyalgia and autoimmune diseases.
• Autoimmune diseases affect approximately 5–8% of the population, with nearly 78% of affected individuals being women, which may contribute to the higher incidence of ocular neuropathic pain observed in females.
• The increasing prevalence of chronic ocular surface disorders, dry eye disease, autoimmune conditions, corneal nerve damage, and chronic pain syndromes is expected to sustain the global NOP burden over the coming years. Improving early diagnosis, enhancing awareness among healthcare professionals, advancing diagnostic technologies, and developing effective targeted therapies will remain key determinants of future trends

Neuropathic Ocular Pain (NOP) Epidemiology Forecast

• 2025 Prevalent Cases of NOP: ~XX Cases
• NOP Growth Rate (2026–2036): ~XX% CAGR

DelveInsight's ‘Neuropathic Ocular Pain (NOP)– Epidemiology Forecast – 2036’ report delivers an in-depth understanding of the NOP, historical and forecasted epidemiology in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Neuropathic Ocular Pain (NOP) Understanding and Diagnosis Algorithm

Neuropathic Ocular Pain (NOP) Overview and Diagnosis

NOP is a chronic ocular pain condition caused by damage or dysfunction of the corneal nerves and somatosensory pathways, often occurring in the absence of significant visible ocular surface abnormalities. The condition is characterized by symptoms such as burning, stinging, dryness, photophobia, foreign body sensation, and severe eye discomfort, frequently associated with dry eye disease, refractive surgery, infections, trauma, autoimmune disorders, or systemic neuropathic conditions. NOP can significantly impair quality of life and is often difficult to diagnose and manage due to the overlap of symptoms with other ocular surface disorders and the complex underlying neuro-inflammatory mechanisms.

Note: Further details are provided in the report.

Diagnosis

NOP is diagnosed through clinical evaluation, patient history, and exclusion of other ocular surface disorders. Diagnostic workup includes ocular surface examination, corneal sensitivity assessment, tear film evaluation, fluorescein staining, and specialized tests such as confocal microscopy or topical anesthetic challenge to identify corneal nerve dysfunction and pain sensitization.

Note: Further details are provided in the report.

Neuropathic Ocular Pain (NOP) Epidemiology

Key Findings from NOP Epidemiological Analysis and Forecast 

• NOP is increasingly recognized among patients with chronic ocular pain and dry eye like symptoms, with variations in disease burden, diagnosis, and clinical presentation across different patient populations and regions.
• In 2025, the United States accounted for the highest number of NOP cases among the 7MM, which is expected to increase throughout the study period.
• The observed female predominance and earlier onset of NOP highlight the importance of early diagnosis, gender-specific risk assessment, and targeted therapeutic strategies to improve disease management and patient outcomes. 

Scope of the Report

• The report covers a segment of an executive summary, a descriptive overview of NOP, explaining its causes, signs and symptoms, and pathogenesis.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.

Report Insights

Neuropathic Ocular Pain (NOP) Patient Population Forecast

Report Key Strengths

• Epidemiology‑based (epi‑based) Bottom‑up Forecasting
• 11-year Forecast 
• Patient Burden Trends (By Geography)

FAQs

• What are the disease risks, burdens, and unmet needs of NOP? What will be the growth opportunities across the 7MM concerning the patient population with NOP?
• What is the historical and forecasted NOP patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy

• Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand key opinion leaders’ perspectives around the diagnostic challenges to overcome barriers in the future.
• Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.